10.02.13
Marken has added a dedicated depot in Moscow, Russia as part of the company’s ongoing expansion of its global pharmaceutical network. The Russia depot will be located within an existing GxP-compliant storage facility in Moscow, providing dedicated space near the airport. Marken’s network also incudes depots in China, Singapore, Argentina, Mexico, Germany, and the U.S.
Marken’s pharma depot facilities provide storage and distribution of materials for clinical trials, including temperature-controlled, time sensitive products. The new facility will be managed by Marken’s global inventory system, Solo, an operating and tracking system that provides 24/7 access and monitoring of global supplies and distribution status, and operated by staff trained on Marken’s global procedures.
Gerit Offenhauser, Marken’s senior vice president of Clinical Trials Distribution, said, “This co-location in Moscow offers clear market opportunities for our clients who have indicated a need for clinical trial operations in Russia and Eastern Europe. We look forward to meeting the growing needs for depot services in that part of the world.”
Marken’s pharma depot facilities provide storage and distribution of materials for clinical trials, including temperature-controlled, time sensitive products. The new facility will be managed by Marken’s global inventory system, Solo, an operating and tracking system that provides 24/7 access and monitoring of global supplies and distribution status, and operated by staff trained on Marken’s global procedures.
Gerit Offenhauser, Marken’s senior vice president of Clinical Trials Distribution, said, “This co-location in Moscow offers clear market opportunities for our clients who have indicated a need for clinical trial operations in Russia and Eastern Europe. We look forward to meeting the growing needs for depot services in that part of the world.”
